Ad
related to: quinacrine availability in us pharmacy group panama capital management
Search results
Results From The WOW.Com Content Network
Mepacrine, also called quinacrine or by the trade names Atabrine or Atebrin, is a medication with several uses. It is related to chloroquine and mefloquine . Although available from compounding pharmacies , as of August 2020 approved formulations are not available in the United States.
Tafenoquine, sold under the brand name Krintafel among others, is a medication used to prevent and to treat malaria. [3] With respect to acute malaria, it is used together with other medications to prevent relapse by Plasmodium vivax. [3]
The Pharmaceutical Care Management Association (PCMA) is an American national trade association representing pharmacy benefit managers.According to the association's mission statement, PCMA advocates on behalf of its member companies, which claim to improve affordability of prescription drugs and quality of care through the use of tools such as electronic prescribing (e-prescribing), [1 ...
Catamaran Corporation (formerly SXC Health Solutions) is the former name of a company that now operates within UnitedHealth Group's OptumRX division (since July 2015). It sells pharmacy benefit management and medical record keeping services to businesses in the United States [3] and to a broad client portfolio, including health plans and employers. [4]
Pages in category "Pharmacy benefit management companies based in the United States" The following 22 pages are in this category, out of 22 total. This list may not reflect recent changes .
The derivatives primaquine, tafenoquine and pamaquine have been tested for anti-malaria activity. [3] [4] Primaquine is still used routinely worldwide as part of the treatment of Plasmodium vivax and Plasmodium ovale malaria, although how it prevents malarial recurrences is not, at present, clear. [5]
4-Aminoquinoline is a form of aminoquinoline with the amino group at the 4-position of the quinoline. The compound has been used as a precursor for the synthesis of its derivatives. [1] A variety of derivatives of 4-aminoquinoline are antimalarial agents useful in treating erythrocytic plasmodial infections. [2]
In October 2020, Hims closed a deal with Oaktree Capital Management to go public through a blank check company, reaching a valuation of $1.6 billion. [7] As part of the deal, the company was renamed Hims & Hers Health Inc. [11] The transaction was completed in January 2021, and the company started trading publicly on the New York Stock Exchange.